Targeted Radiation For Prostate Cancer Lessens Complications

November 3, 2010

United Press International and HealthDay News

United Press International and HealthDay News stories highlighted research conducted by Justin Bekelman, MD, an assistant professor of Radiation Oncology, which showed that prostate cancer patients who received intensity modulated radiation therapy were less likely to suffer gastrointestinal complications compared to patients treated with conventional three-dimensional conformal radiotherapy. The results of the study were presented at this week's annual meeting of the American Society for Radiation Oncology (ASTRO). "With survivors living many years after treatment, it is very important to minimize gastrointestinal and urinary side effects to allow patients to live a full life after treatment," Bekelman says.

United Press International article
HealthDay article